Warning message

The subscription service is currently unavailable. Please try again later.

Award-winning researcher engineers cannabis strain with 20% more THC


Levels for THC and CBG were increased by 17 per cent and 25 per cent more, respectively.

Researchers from the University of Jerusalem have managed to manipulate the number of cannabinoids within a cannabis plant.

According to The Jerusalem Post, the research increased the plant’s THC level to 20 per cent more, something that could help create new strains with more medicinal power and to help boost crop yields.

The researchers were led by Professor Alexander Vainstein and managed to increase a variety of cannabinoid levels, including for THC and cannabigerol (CBG), which were increased by 17 per cent more and 25 per cent more, respectively.


Cancer pain treatment using marijuana safe and effective, large study finds


Scientists have gathered evidence showing cannabis significantly improves the symptoms of cancer patients, with minimal side effects.

In a paper published last week in the journal Frontiers in Pain Research, researchers from Israel stated that cannabis could be a promising alternative to the current standard opioid pain relief offered to cancer patients, which can cause addiction and other negative side effects. Medicinal cannabis use also has side effects, ranging from nausea and weakness to psychosis. However, as the paper says, "the adverse effects from cannabinoids for cancer treatment are generally well tolerated by the patients and categorized as mild to moderate."


First-ever export of Israeli medical cannabis seeds heads to US


Agriculture Ministry hails development as a major step toward country becoming a significant player in the global cannabis market

The first-ever export shipment of Israeli cannabis seeds has left for the US, the Agriculture Ministry said in a statement Wednesday, hailing the move as a major step toward becoming a global pioneer in the field.

Efforts to arrange the “experimental and initial” shipment, which departed on Tuesday night, have been ongoing for the past year.

The cargo contained seeds from the local BetterSeeds company, which has a research license from the Health Ministry.

They will be examined on arrival “to verify their suitability for the US market,” the ministry said.


Israeli company to unveil psilocybin nasal spray system


A modern approach to delivering small doses of psilocybin for the treatment of mental conditions is coming to fruition in Israel.

Israeli biopharmaceutical company Madrigal Mental Care will unveil novel nanotechnology to deliver psilocybin via nasal spray for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, on May 10-12, 2022, at the David InterContinental Hotel in Tel Aviv, Israel, according to a May 9 press release.

Biomed Israel is a broad celebration of the life science and technology industries. At past events, the event attracted over 6,000 attendees, with 1,000 attending internationally from over 45 countries.


The demand for medical cannabis in Israel is growing like a weed

Israeli Flags


When it comes to emerging international cannabis markets, Israel is one of the first countries to come to mind. (Technical 420)

From researching medical cannabis for more than 50 years to being able to cultivate for a fraction of the cost in North America, we are bullish on the economics and the long-term growth prospects that are associated with the Israeli market.

In mid-2020, Israel overtook Germany as the largest importer of medicinal cannabis in the world (according to data from Tel Aviv-based Cannabis Magazine and Marijuana Business Daily) and have noticed increased interest in the region as a result.


Cannabis sales grow in Israel

Israeli flag

The Lod-based company Panaxia reported increased revenues from the Israeli market for its sales of medical cannabis in 2021.

The Israeli cannabis company Panaxia released its earnings for 2021 Tuesday. 

Panaxia, which is based in the mixed Arab-Jewish city of Lod, said its net Israeli revenues increased 38% to $83.6 million, according to a press release. 

Panaxia also began exporting medical cannabis oils abroad in late 2020. Export revenues for 2020 and 2021 were $5.6 million, per the release. 

Panaxia’s stock increased by 0.45% today to 67.10 Israeli shekels ($20.94). 


Mixing medical mushrooms and cannabis for cancer care

man holding cannabis flower


Cannabotech’s idea is not to replace existing cancer treatments but to enable a patient to have fewer treatments with the same benefit.

Can cannabis cure breast cancer? Not yet, unfortunately. But according to Herzliya-based startup Cannabotech, when paired with medical mushrooms cannabis may one day be able to reduce the amount of chemotherapy patients need to take.

“We know that patients need a minimum amount of chemo, but a lot of people can’t survive this because of side effects, so they stop the treatment,” explains Elchanan Shaked, CEO of Cannabotech.

Taking a Cannabotech supplement could shift the balance, claims the company.


Israel announces new cannabis decriminalization plans

flag of Israel

Israel, the “Startup-Nation,” published new guidelines last week to eliminate criminal penalties for consumption.

Israeli Justice Minister Gideon Sa’ar proposed new guidelines last week which further move the consumption of cannabis away from a criminal offense and propose essentially creating an administrative one, punishable with a maximum fine of 1,000 shekels (about $310). Fines would also be limited for members of the Israeli Defense Forces, police, and minors who are excluded from the new regulation. Possession will now be treated like a traffic offense.


Israeli company uses cannabis for women's health solutions

women exercise

Sagiv says 'If we know how to target this endocannabinoid system… we will know how to treat these conditions'

Gynica, an Israel-based company, is looking to address several medical conditions in women’s health through the use of an unconventional treatment method - cannabis.

Dr. Sari Pruychi Sagiv, vice president of research and development at Gynica, sat down with i24NEWS to explain how women’s health concerns can be managed with the pharmacological use of cannabis.

“We know that for thousands of years, women have been using cannabis or cannabis extract for women’s health conditions such as painful menstruation,” Sagiv explained.


Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel

Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today the pre-launch of its first-generation medical cannabis inflorescence products.


Subscribe to RSS - Israel